About Fabian Johnston
Hyperthermic Intraperitoneal Chemotherapy
As a surgical oncologist, Dr. Johnston often treats peritoneal mesothelioma patients with a combination of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Johnston also has expertise in pancreatic cancer, colorectal cancer, gastroesophageal cancer, stomach cancer and neuroendocrine tumors.
He takes pride in his family-centric approach, going beyond the traditional clinical relationship when treating patients diagnosed with abdominal cancers.
“Cancer is a family disease. It effects not just the individual, but the family as a whole,” Johnston said. “As a patient, you’re part of my family, and we’re part of one team. You’re the quarterback. I’m the coach. And our job is to try and score a touchdown and beat this horrible disease.”
Johnston developed his family philosophy to treatment early in his career — much of it during his nine years as an assistant professor of surgery at the Medical College of Wisconsin.
He joined Johns Hopkins in 2016 as an associate professor, returning closer to many members of his own extended family.
“We, in the medical field, often don’t address the other needs that cancer patients can have,” Johnston said. “We often talk about medical symptoms and disease but not enough about how they are doing, the psycho-social aspects of care, the spiritual needs of a family. That’s part of my philosophy. I look forward to taking care of a patient and his family in my clinic.”
Johnston also is involved in research that has worked to improve the utilization of palliative care and improving quality of life for patients with advanced malignancies.
He has taken a leadership role in various organizations, including the Association of Academic Surgeons and the American College of Surgeons for Surgical Palliative Care.
His expertise in the cytoreductive surgery/HIPEC combination has helped extend survival significantly for several abdominal cancers, including peritoneal mesothelioma.
In one recent study, the median overall survival for patients who underwent the combination treatment was 6.65 years. And almost 30 percent of the patients had a survival estimate of 10 years or more.
Johnston, who moved to the United States at age 2, earned his degree from Pennsylvania State University College of Medicine. He did his undergraduate work at State University of New York, and he completed residencies at Louisiana State University and Washington University in St. Louis.
He did his fellowships at Washington University and Johns Hopkins before taking a position at the Medical College of Wisconsin.
Disclaimer: Dr. Fabian Johnston has no professional affiliation with Asbestos.com.
2 Cited Article Sources
The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.
StephanieK. (n.d.). Jamaican, Dr. Fabian Johnston Leads Cancer Research Program at Johns Hopkins.
Retrieved from: https://jamaicans.com/jamaican-dr-fabian-johnston-leads-cancer-research-program-johns-hopkins/
- Johns Hopkins. (n.d.). Fabrian Johnston, M.D. Retrieved from: https://www.hopkinsmedicine.org/profiles/results/directory/profile/10003356/fabian-johnston
How did this article help you?
What about this article isn’t helpful for you?
Did this article help you?
Share this article
Last Modified November 22, 2019